2
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Addition of gonadotrophin-releasing hormone agonist and/or two inseminations with husband's sperm do not improve the pregnancy rate in superovulated cycles

, &
Pages 37-42 | Published online: 07 Aug 2009

References

  • Meldrum DR, Wisot A, Hamilton F, Gutlay AL, Kempton W Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrieval. Fertil Steril 1989; 51: 455–9.
  • Neveu S, Hedon B, Bringer J, Chinchole J, Arnal F, Humeau C et al. Ovarian stimulation by a combination of a gonadotropin-releasing hormone agonist and gonadotropins for in vitro fertilization. Fertil Steril 1987; 47, 639–43.
  • Dodson WC, Walmer DK, Hughes CL, Yancy SE, Haney AF. Adjunctive leuprolide therapy does not improve cycle fecundity in controlled ovarian hyperstimulation and intrauterine insemination of subfertile women. Obstet Gynecol 1991; 78: 187–90.
  • Gagliardi CL, Emmi AM, Weiss G. Schmidt CL. Gonadotropin-releasing hormone agonist improves the efficiency of controlled ovarian hyperstimulation/intrauterine insemination. Fertil Steril 1991; 55: 939–44.
  • Abbasi R, Kenigsberg D, Danforth D. Cumulative ovulation rate in human menopausal/human chorionic gonadotropin-treated monkeys: ‘step-up’ versus ‘step-down’ dose regimens. Fertil Steril 1987; 47: 1019–24.
  • Karlström PO, Bergh T, Lundkvist O. A prospective randomized trial of artificial insemination versus intercourse in cycles stimulated with human menopausal gonadotropin or clomiphene citrate. Fertil Steril 1993; 59: 554–9.
  • American Fertility Society Revised American Fertility Society classification of endometriosis. Fertil Steril 1985; 43: 351–2.
  • World Health Organization. Laboratory Manual for the examination of Human Semen and Semen-Cervical Mucus Interaction, 1987.
  • Armitage P Statistical Methods in Medical Research. 1st edn. Oxford: Blackwell Scientific Publications. 1971: pp. 226–39.
  • Karlström PO, Bakos O, Bergh T, Lundkvist Ö. Hormone and ultrasound parameters in ovarian stimulation cycles for direct intraperitoneal insemination. Hum Reprod 1992; 7: 813–20.
  • Sengoku K, Tamate K, Takaoka Y, Morishita N, IshikawaM. A randomized prospective study of gonadotrophin with or without gonadotrophin-releasing hormone agonist for treatment of unexplained infertility. Hum Reprod 1994; 9: 1043–7.
  • Manzi DL, Dumez S, Scott LB, Nulsen JC. Selective use of leuprolide acetate in women undergoing superovulation with intrauterine insemination results in significant improvement in pregnancy outcome. Fertil Steril 1995; 63: 866–73.
  • Nuoja-Huttunen S, Tuomivaara L, Juntunen K, Tomàs C, Martikainen H. Long gonadotrophin releasing hormone agonist/human menopausal gonadotrophin protocol for ovarian stimulation in intrauterine insemination treatment. Eur J Obstet Gynecol Reprod Biol 1997; 74: 83–7.
  • Hughes EG, Fedorkow DM, Daya S, Sagle MA, Van de Koppel P, Collins JA. The routine use of gonadotropinreleasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials (see comments). Fertil Steril 1992; 58: 888–96.
  • Rutherford AJ, Subak-Sharpe RJ, Dawson KJ, Margara RA, Franks S, Winston ML. Improvement of in vitro fertilisation after treatment with buserelin, an agonist of luteinising hormone releasing hormone. Br Med J 1988; 296: 1765–8.
  • Abdalla HI, Ahuja KK, Leonard T, Morris N, Honour J, Jacobs H. Comparative trial of luteinizing hormone-releasing hormone analog/human menopausal gonadotropin and clomiphene citrate/human menopausal gonadotropin in an assisted conception program. Fertil Steril 1990; 53: 473–8.
  • Stanger JD, Yovich JL. Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase. Br J Obstet Gynaecol 1985; 92: 385–93.
  • Schoolcraft W, Sinton E, Schlenker T, Huynah D, Hamilton F, Meldrum DR. Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate. Fertil Steril 1991; 55: 563–6.
  • Dodson WC, Haney AF. Controlled ovarian hyperstimulation and intrauterine insemination for treatment of infertility (see comments). Fertil Steril 1991; 55: 457–67.
  • Dickey RP, Olar TO, Taylor SN, Curole DN, Rye PH, Matulich EM. Relationship of follicular number, serum estradiol, and other factors to birth rate and multiparity in human menopausal gonadotropininduced intrauterine insemination cycles. Fertil Steril 1991; 56: 89–92.
  • Deaton JL, Clark RR, Pittaway DE, Herbst P, Bauguess P. Clomiphene citrate ovulation induction in combination with a timed intrauterine insemination: the value of urinary luteinizing hormone versus human chorionic gonadotropin timing. Fertil Steril 1997; 68: 43–7.
  • Valbuena D, Simün C, Romero JL, Remohi J, Pellicer A. Factors responsible for multiple pregnancies after ovarian stimulation and intrauterine insemination with gonadotropins. J Assist Reprod Genet 1996; 13: 663–8.
  • Shelden R, Kemmann E, Bohrer M, Pasquale S. Multiple gestation is associated with the use of high sperm numbers in the intrauterine insemination specimen in women undergoing gonadotropin stimulation. Fertil Steril 1988; 49: 607–10.
  • Silverberg KM, Johnson JV, Olive DL, Burns WN, Schenken RS. A prospective, randomized trial comparing two different intrauterine insemination regimens in controlled ovarian hyperstimulation cycles. Fertil Steril 1992; 57: 357–61.
  • Ransom MX, Blotner MB, Bohrer M, Corsan G, Kemmann E. Does increasing frequency of intrauterine insemination improve pregnancy rates significantly during superovulation cycles? Fertil Steril 1994; 61: 303–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.